Social Mycology: Using Social Media Networks in the Management of Aspergillosis and Other MycosesOpinion Article Published on 2023-04-062024-09-05 Journal: Mycopathologia [Category] update2024, [키워드] aspergillosis Aspergillus mycology [DOI] 10.1007/s11046-023-00726-0 PMC 바로가기 [Article Type] Opinion Article
Evaluation of Topical Antifungals Using a New Predictive Animal Model for Efficacy against Severe Tinea Unguium: A Comparison of Efinaconazole and Luliconazole심한 손발톱곰팡이증에 대한 효능을 평가하기 위한 새로운 예측 동물 모델을 사용한 국소 항진균제의 평가: 에피나코나졸과 루리코나졸의 비교Article Published on 2022-09-122024-07-29 Journal: Mycopathologia [Category] 백선증, [키워드] Arthrospore in vivo model mycology Severe onychomycosis Topical antifungal drug [DOI] 10.1007/s11046-022-00664-3 PMC 바로가기
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis StudyObservational Study Published on 2022-04-202022-10-05 Journal: Journal of Clinical Microbiology [Category] 임상, [키워드] 95% CI adjusted Analysis aspergillosis Aspergillus association BALF Biomarker Bronchoalveolar lavage fluid can be used CAPA Combination conducted confidence interval coronavirus disease COVID-19 Critically ill patient Culture develop diagnosed enrolled European final multivariable model galactomannan galactomannan. GM hazard ratio heterogeneity Impact increasing age independent independent predictor intensive care unit lavage malignant disease Mortality MOST multicenter mycology optical Patient positive prognostic Prognostic value pulmonary Result survival with COVID-19 [DOI] 10.1128/jcm.02298-21 PMC 바로가기 [Article Type] Observational Study
COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020–March 2021Article Published on 2021-11-102022-10-30 Journal: Journal of Fungi [Category] COVID-19, [키워드] animal Antifungal Aspergillus CAPA Care Consensus coronavirus disease COVID-19 criteria Culture cultures death European experience Fever Human ICU incidence incidence rates intensive care unit Invasive pulmonary aspergillosis large cohort management mycology overall mortality pandemic Patient positive positive COVID-19 pulmonary report Severe COVID-19 Infection Society study period study population Support the patient Treatment Valley were given worsening respiratory failure [DOI] 10.3390/jof7110948 PMC 바로가기 [Article Type] Article
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis 1Observational Study Published on 2021-11-012022-10-04 Journal: Emerging Infectious Diseases [Category] MERS, SARS, 임상, [키워드] aspergillosis Aspergillus Cohort cohorts coronavirus coronavirus disease COVID-19 Epidemiology Factor fungi incidence intensive care Invasive pulmonary aspergillosis mortality rate mortality rates mycology outcome Patient performed pulmonary respiratory infections Risk factors SARS SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses zoonoses [DOI] 10.3201/eid2711.211174 PMC 바로가기 [Article Type] Observational Study
10th Trends in Medical Mycology Held on 8 to 11 October 2021, Aberdeen, Scotland, Organized by the European Confederation of Medical Mycology (ECMM)Conference Report Published on 2021-10-282022-10-30 Journal: Journal of Fungi [Category] COVID-19, [키워드] European Held mycology trend [DOI] 10.3390/jof7110916 PMC 바로가기 [Article Type] Conference Report
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational studyObservational Study Published on 2021-09-152022-10-04 Journal: Critical Care [Category] 임상, [키워드] 95% CI animal Antifungal ARF baseline characteristics CAPA clinical outcomes Complication consecutive patient Consensus Controlled trial coronavirus disease 19 COVID-19-associated aspergillosis criteria Critically ill diagnosed Efficacy and safety estimate European evaluate fungal hazard ratio Human ICU ICU admission ICU patient incidence intensive care unit median Mortality mould Mould prophylaxis mycology Mycose no difference Patient patients Posaconazole Prevent Primary outcome Propensity score Prophylaxis reduced Respiratory failure Result secondary outcome significantly Society supplementary material survival translate was performed were recorded with COVID-19 [DOI] 10.1186/s13054-021-03753-9 PMC 바로가기 [Article Type] Observational Study
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries저소득 및 중간 소득 국가에서 COVID-19 관련 점막 진균증의 임상 관리를 위한 ECMM/ISHAM 권장 사항Article Published on 2021-09-012022-09-12 Journal: Mycoses [Category] SARS, 진단, [키워드] animal antifungal therapy Care Clinical management clinician Corticosteroid corticosteroid therapy Corticosteroids country COVID-19 COVID-19 patient diabetes Diabetes Mellitus diagnosing Diagnosis disease Endothelial cell Epidemic European Factor Factors Glucose glycaemic control GRP help High dose Human immunosuppressive Immunotherapy increased expression India indicated Infection management Misconception Mucorale Mucorales Mucormycosis mycology occur Protein provide recommendation regulated report SARS-CoV-2 Society spore surgical the disease tissues uncontrolled [DOI] 10.1111/myc.13335 PMC 바로가기 [Article Type] Article
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical MycologyObservational Study Published on 2021-08-262022-10-04 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 임상, [키워드] 95% CI adjusted hazard ratio Aspergillus conducted Consensus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019-associated pulmonary aspergillosis country COVID-19 COVID-19 patients Critically ill defined determine diagnosed Epidemiology European Factor ICU ICU admission independent intensive care unit invasive respiratory support invasive ventilation median Mortality mycology nine objective older patient older patients outcome Patient patients with COVID-19 predictor Prevalence prevalent prognostic receiving remained Result risk factor significantly lower significantly more survival survival rate Tocilizumab [DOI] 10.1016/j.cmi.2021.08.014 PMC 바로가기 [Article Type] Observational Study
Epidemiology and Mycology of Candidaemia in non-oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non-COVID-19 and COVID-19 cases미국 3차 센터의 비종양내과 중환자실 환자의 칸디다혈증 역학 및 균류: 비COVID-19 및 COVID-19 사례 간의 종합 분석 및 비교Article Published on 2021-06-012022-09-11 Journal: Mycoses [Category] SARS, 치료기술, [키워드] accounted Admissions analysed Analysis Candida albicans Candidaemia candidiasis Central venous catheter Characteristics coronavirus COVID-19 COVID-19 case COVID-19 group COVID-19 patient COVID-19 patients Critical care Critically ill Critically ill patient critically ill patients determine disease distribution Epidemiology globe ICU ICU admission ICUs identify incidence intensive care invasive invasive candidiasis isolates less medical icu medical intensive care unit mycology mycology. Non-COVID-19 non-COVID-19 and COVID-19 patients non-COVID-19 group non-COVID-19 patient Non-COVID-19 patients occurred pandemic Patient provide SARS-CoV-2 pandemic SOFA score the patient the SARS-CoV-2 the United State United States venous catheter [DOI] 10.1111/myc.13258 PMC 바로가기 [Article Type] Article